Eficacia y seguridad de una nueva formulación de enjuague bucal de dexametasona para el manejo de la estomatitis en pacientes con cáncer

Fernández-Sala, Xènia; Barceló-Vidal, Jaime; Tusquets, Ignasi; Conde-Estévez, David.
Farm. hosp ; 45(1): 41-44, ene.-feb. 2021. tab
Artículo en Español | IBECS (España) | ID: ibc-202360

Documentos relacionados

  1. Effectiveness and safety of a novel dexamethasone mouthwash formulation in managing stomatitis in cancer patients.
  2. Dexamethasone to prevent everolimus-induced stomatitis (Alliance MIST Trial: A221701).
  3. Phase 2 study of afatinib among patients with recurrent and/or metastatic esophageal squamous cell carcinoma.
  4. Oral Care Evaluation to Prevent Oral Mucositis in Estrogen Receptor-Positive Metastatic Breast Cancer Patients Treated with Everolimus (Oral Care-BC): A Randomized Controlled Phase III Trial.
  5. EFFICACY AND SAFETY OF A DEXAMETHASONE-BASED MOUTHWASH TO PREVENT CHEMOTHERAPY-INDUCED STOMATITIS IN WOMEN WITH BREAST CANCER: A MULTICENTRE, OPEN-LABEL, RANDOMISED PHASE 2 STUDY.
  6. The effect of systemic application of propolis on tongue damage and oral mucositis in rats exposed to radiation.
  7. Everolimus Concentration in Saliva to Predict Stomatitis: A Feasibility Study in Patients with Cancer.
  8. The therapeutic effects of apigenin and dexamethasone on 5-fluorouracil-induced oral mucositis - a pilot study using a Syrian hamster model.
  9. Evaluation of Miracle Mouthwash plus Hydrocortisone Versus Prednisolone Mouth Rinses as Prophylaxis for Everolimus-Associated Stomatitis: A Randomized Phase II Study.
  10. Prevention and the treatment of oral mucositis: the efficacy of sodium bicarbonate vs other agents: a systematic review.